Cécile Dupont
Partner
Works at Sofinnova
Investor profile | Builders Republic
About
Partner at Sofinnova, Cécile Dupont invests from pre-seed to growth with check sizes ranging from €1M to €60M, particularly in health and life sciences, climate and cleantech, and agri-food. She has been a Partner in the MD Start Strategy since 2019 and is the CEO of BrightHeart. She was the CEO of HEPTA Medical, COO of Gradient Denervation Technologies, and a director at SafeHeal. The track record includes BrightHeart, Endoron Medical, and HEPTA Medical. A graduate of UTC, with a background in corporate finance from HEC.
Profile
- Role
- Partner
- Fund
- Sofinnova